Thalassemia Treatment Market According to MRFR analysis, Thalassemia Treatment Market is expected to register a CAGR of 10.4% during the forecast period and was valued at USD 1890.4 Million in 2018. Thalassemia is an inherited blood disorder that is characterized by inadequate hemoglobin and fewer red blood cells in the body than normal. Hemoglobin is the substance in...